市场调查报告书
商品编码
1470448
机器人内视镜设备市场:按产品、应用和最终用户划分 - 全球预测 2024-2030Robotic Endoscopy Devices Market by Product (Diagnostic, Therapeutic), Application (Bronchoscopy, Colonoscopy, Laparoscopy), End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年机器人内视镜设备市场规模为26亿美元,2024年将达30.9亿美元,2030年将达到86.4亿美元,复合年增长率为18.65%。
机器人内视镜是一种机器人系统,可导航人体复杂的解剖结构并执行微创诊断和治疗程序。这些仪器使内视镜过程的部分自动化,从而实现更一致和精确的操作。机器人内视镜设备具有高精度和可操作性,可实现微创手术,提高可视性和灵活性。与传统内视镜不同,机器人内视镜设备的使用可以进行更复杂的手术并改善患者的治疗效果。随着高龄化社会的到来,需要机器人内视镜手术。对医疗基础设施的投资增加和采用新技术的意愿是采用机器人内视镜设备的关键驱动力。此外,患者对微创手术的偏好不断增加,正在推动机器人内视镜设备的引入。然而,机器人内视镜系统及其维护的高昂成本可能会让一些医疗保健提供者望而却步。医疗保健提供者需要进行技术培训才能操作这些先进的系统,这可能会阻碍机器人内视镜设备的采用。也就是说,机器人内视镜的持续技术创新和研究不断揭示机器人内视镜设备渗透的新机会。此外,整合人工智慧以增强诊断能力和改善手术自动化预计将为未来机器人内视镜设备提供巨大的成长潜力。
主要市场统计 | |
---|---|
基准年[2023] | 26亿美元 |
预测年份 [2024] | 30.9亿美元 |
预测年份 [2030] | 86.4亿美元 |
复合年增长率(%) | 18.65% |
扩大诊断机器人内视镜装置的使用,增强产品影像诊断功能
诊断机器人内视镜设备旨在促进详细的内部检查以诊断各种病症。这些设备提供增强的影像处理能力、可操作性和稳定性,这对于检测肿瘤、溃疡和其他消化器官系统疾病等身体异常非常重要。对诊断机器人内视镜设备的偏好是基于对提供高精度和高效诊断的微创手术的需求。治疗性机器人内视镜设备提供切片检查、息肉切除术和内视镜黏膜切除术等介入措施。治疗设备包含精密仪器和控制系统,可在患者体内以最小的切口进行精细的外科手术。治疗性机器人内视镜设备特别适用于需要高精度和控制的手术,例如肿瘤学和复杂的胃肠道手术。
最终用户:医院广泛采用机器人内视镜设备
门诊手术中心是提供当天手术治疗的设施,包括诊断和预防程序。 ASC 更喜欢机器人内视镜设备,以提高手术效率,以便他们每天可以执行更多手术。医院提供从急诊护理到专科护理的广泛服务,通常包括先进的外科手术。医院中的机器人内视镜用于需要精确和专业护理的复杂手术。医院优先考虑最新、最先进的机器人内视镜设备来处理复杂的病例和研究应用。该程序的复杂性使得强大的培训计划和持续的支援服务对医院来说更加重要。医院将投资于技术进步和整合能力,使他们能够处理更复杂和多样化的程序。 ASC 可能会优先考虑更快的恢復技术,以促进当天出院,而医院可能会专注于提供更高精度和控制的设备,儘管初始投资更高。
区域洞察
美洲是一个快速发展的新兴市场,拥有先进的医疗基础设施、高昂的医疗成本以及大量的研发投资。该区域市场的特点是消费者意识不断增强,对微创外科手术的需求不断增加,推动了机器人内视镜设备的采用。大量製造商的存在和有利的报销环境也正在推动美洲机器人内视镜设备市场的发展。欧洲市场多元化,欧盟国家拥有先进的医疗保健系统,专注于改善手术结果和患者照护品质。人口老化、医疗保健政策和具有成本效益的医疗保健服务正在推动机器人内视镜设备在欧盟的部署。中东正大力投资医疗基础设施,以成为医疗旅游中心。非洲是机器人内视镜设备的新兴市场,那里的医疗保健系统正在逐步加强,新的医疗技术正在引入。由于医疗成本上升、经济成长和患者意识的提高,亚太地区正在发展机器人内视镜设备市场。随着投资的增加和对负担得起的解决方案的关注,亚太地区的医疗保健格局正在改变。
FPNV定位矩阵
FPNV 定位矩阵对于评估机器人内视镜设备市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对机器人内视镜设备市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,以获得市场竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4.竞争评估及资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行综合评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.机器人内视镜设备市场规模及预测为何?
2.机器人内视镜设备市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些?
3.机器人内视镜设备市场的技术趋势和法规结构是什么?
4.机器人内视镜设备市场主要厂商的市场占有率是多少?
5.进入机器人内视镜设备市场的合适型态和策略手段是什么?
[190 Pages Report] The Robotic Endoscopy Devices Market size was estimated at USD 2.60 billion in 2023 and expected to reach USD 3.09 billion in 2024, at a CAGR 18.65% to reach USD 8.64 billion by 2030.
Robotic endoscopy devices consist of robotic systems that help navigate the human body's complex anatomy to perform diagnostic and therapeutic procedures with minimal invasiveness. These devices automate parts of the endoscopic process, allowing for more consistent and accurate manipulations. The robotic endoscopy devices offer high precision and control, allowing for minimally invasive surgeries with enhanced visualization and dexterity. Unlike traditional endoscopy, robotic endoscopy devices enable clinicians to perform more complex procedures with improved patient outcomes. An aging population experiencing a higher incidence of conditions requires robotic endoscopic procedures. Increased investment in healthcare infrastructure and the willingness to adopt new technologies are crucial drivers for adopting robotic endoscopy devices. In addition, rising patient preference for minimally invasive surgeries supports deploying robotic endoscopic devices. However, the high cost of robotic endoscopy systems and their maintenance can be prohibitive for some healthcare providers. The requirement for technical training for healthcare providers to operate these advanced systems can hinder the adoption of robotic endoscopy devices. Nevertheless, the ongoing innovation and research in robotic endoscopy continuously unveils new opportunities to penetrate robotic endoscopy devices. Moreover, integrating artificial intelligence for enhanced diagnostic abilities and improved surgical automation is expected to present significant growth potential for robotic endoscopy devices in the coming years.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 2.60 billion |
Estimated Year [2024] | USD 3.09 billion |
Forecast Year [2030] | USD 8.64 billion |
CAGR (%) | 18.65% |
Product: Significant usage of diagnostic robotic endoscopy devices to enhance imaging capabilities
Diagnostic robotic endoscopy devices are designed to facilitate detailed internal examinations to diagnose various conditions. These devices offer enhanced imaging capabilities, maneuverability, and stability, which are critical in detecting bodily abnormalities, such as tumors, ulcers, and other gastrointestinal conditions. The preference for diagnostic robotic endoscopy devices is based on the need for minimally invasive procedures that provide high accuracy and efficiency in diagnosis. Therapeutic robotic endoscopy devices provide interventions such as biopsies, polypectomies, and endoscopic mucosal resections. Therapeutic devices incorporate precision instrumentation and control systems to enable delicate surgical procedures within the patient's body with minimal incisions. The preference for therapeutic robotic endoscopy devices is higher in procedures that demand high precision and control, particularly in oncology and complex gastrointestinal surgeries.
End-User: Wide adoption of robotic endoscopy devices in hospital settings
Ambulatory surgical centers are facilities that provide same-day surgical care, including diagnostic and preventive procedures. ASCs prefer robotic endoscopy devices that increase procedural efficiency, allowing for more procedures to be performed daily. Hospitals encompass a wide range of acute and specialized care services, which often include advanced surgical interventions. Robotic endoscopy in hospitals caters to complex procedures requiring precision and specialized care. Hospitals prioritize the latest and most advanced robotic endoscopy devices for complex cases and research applications. A robust training program and ongoing support services are more critical for hospitals due to the complexity of the procedures. Hospitals invest in technological advancements and integration capacities that lend themselves to more complex and varied procedures. ASCs may prioritize faster recovery technologies to facilitate same-day discharge, while hospitals might focus on devices that offer a higher level of precision and control, even if the initial investment is higher.
Regional Insights
The Americas represents a rapidly developing robotic endoscopy devices market owing to the advanced healthcare infrastructure, high healthcare expenditure, and significant investment in research and development. The regional market is characterized by increased consumer awareness and a growing demand for minimally invasive surgical procedures, which drives the adoption of robotic endoscopy devices. The presence of majority manufacturers and a favorable reimbursement environment also encourage the robotic endoscopy devices market in the Americas. The European market is diverse, with advanced healthcare systems in EU countries focusing on improving surgical outcomes and patient care quality. The aging population, healthcare policies, and an emphasis on cost-efficient healthcare delivery encourage the deployment of robotic endoscopy devices in the EU. The Middle East invests heavily in healthcare infrastructure to become a medical tourism hub. Africa presents a nascent market for robotic endoscopy devices with progressively strengthening healthcare systems and ongoing adoption of new medical technologies. The Asia Pacific region represents an evolving robotic endoscopy devices market owing to the increasing healthcare expenditure, growing economies, and rising patient awareness. Asia-Pacific's healthcare landscape is transforming with increased investments and a focus on affordable solutions.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Robotic Endoscopy Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Robotic Endoscopy Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Robotic Endoscopy Devices Market, highlighting leading vendors and their innovative profiles. These include Ambu A/S, Asensus Surgical, Inc., avateramedical GmbH, Boston Scientific Corporation, Brainlab AG, Canady Life Sciences, Inc., CMR Surgical Ltd., Cook Group Incorporated, ENDO Robotics Co., LTD., EndoMaster Pte Ltd, Endotics, Globus Medical, Inc., Intuitive Surgical, Inc., Johnson & Johnson Services Inc., KARL STORZ SE & Co. KG, Medtronic PLC, MicroPort Scientific Corporation, Nitinotes Ltd., Olympus Corporation, Otsuka Holdings Co., Ltd., Renishaw PLC, Ronovo Surgical, Stryker Corporation, and Virtuoso Surgical, Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Robotic Endoscopy Devices Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Robotic Endoscopy Devices Market?
3. What are the technology trends and regulatory frameworks in the Robotic Endoscopy Devices Market?
4. What is the market share of the leading vendors in the Robotic Endoscopy Devices Market?
5. Which modes and strategic moves are suitable for entering the Robotic Endoscopy Devices Market?